|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
- Name Benzoctamine
- EINECSN/A
- CAS No. 17243-39-9
- Density1.114g/cm3
- PSA12.03000
- LogP3.82210
- SolubilityN/A
- Melting PointN/A
- FormulaC18H19N
- Boiling Point372°C at 760 mmHg
- Molecular Weight249.356
- Flash Point181.1°C
- Transport InformationN/A
- AppearanceN/A
- SafetyA poison by intraperitoneal, subcutaneous, amd intravenous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic vapors of NOx.
- Risk CodesN/A
- Molecular Structure
- Hazard SymbolsModerately toxic by ingestion.
- SynonymsModerately toxic by ingestion.
- Article Data1
Benzoctamine Chemical Properties
Product Name: Benzoctamine
Synonyms of Benzoctamine (CAS NO.17243-39-9): Benzoctamine [INN:BAN] ; BRN 2811058 ; Benzoctamina ; Benzoctamina [INN-Spanish] ; Benzoctaminum ; Benzoctaminum [INN-Latin] ; Benzoktamina ; Benzoktamina [Polish] ; UNII-734MM7Y191 ; 9,10-Ethanoanthracene-9(10H)-methanamine, N-methyl- (9CI) ; 9,10-Ethanoanthracene-9(10H)-methylamine, N-methyl- (7CI,8CI) ; Ethanoanthracene-9(10H)-methylamine, N-methyl-
CAS NO: 17243-39-9
Molecular Formula of Benzoctamine (CAS NO.17243-39-9): C18H19N
Molecular Weight: 249.3502
H bond acceptors: 1
H bond donors: 1
Freely Rotating Bonds: 2
Polar Surface Area: 3.24 Å2
Index of Refraction: 1.619
Molar Refractivity: 78.5 cm3
Molar Volume: 223.7 cm3
Surface Tension: 48.6 dyne/cm
Density of Benzoctamine (CAS NO.17243-39-9): 1.114 g/cm3
Flash Point: 181.1 °C
Enthalpy of Vaporization: 61.91 kJ/mol
Boiling Point: 372 °C at 760 mmHg
Vapour Pressure: 9.91E-06 mmHg at 25°C
Molecular Structure:
.png)
Benzoctamine Uses
Benzoctamine is a drug. Benzoctamine is used as sedative and anxiolytic properties. This drug is also used as a sedative in the hospital scene in patients who have respiratory failure.
Benzoctamine Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD50 | intravenous | > 10mg/kg (10mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| dog | LD50 | intravenous | > 10mg/kg (10mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| dog | LD50 | oral | > 200mg/kg (200mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| mouse | LD50 | intraperitoneal | 120mg/kg (120mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR BEHAVIORAL: MUSCLE WEAKNESS | Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 40, Pg. 235, 1983. |
| mouse | LD50 | intravenous | 30mg/kg (30mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| mouse | LD50 | oral | 280mg/kg (280mg/kg) | PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| rabbit | LD50 | oral | 800mg/kg (800mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| rabbit | LD90 | intravenous | 30mg/kg (30mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| rat | LD50 | intraperitoneal | 125mg/kg (125mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 40, Pg. 235, 1983. |
| rat | LD50 | intravenous | 36mg/kg (36mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| rat | LD50 | oral | 600mg/kg (600mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
| rat | LD50 | subcutaneous | 240mg/kg (240mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 201, Pg. 25, 1973. |
Benzoctamine Safety Profile
A poison by intraperitoneal, subcutaneous, amd intravenous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic vapors of NOx.
What can I do for you?
Get Best Price
- Benzoctamine
- Benzoctamine hydrochloride
- 1724-39-6Cyclododecanol
- 172451-37-5L-Arginine,glycyl-L-a-aspartyl-L-cysteinyl-L-leucyl-L-prolyl-L-histidyl-L-leucyl-L-lysyl-L-arginyl-L-cysteinyl-L-lysyl-L-alanyl-L-a-aspartyl-L-asparaginyl-L-a-aspartyl-L-cysteinyl-L-cysteinylglycyl-L-lysyl-L-lysyl-L-cysteinyl-L-lysyl-L-arginyl-L-arginylglycyl-L-threonyl-L-asparaginyl-L-alanyl-L-a-glutamyl-L-lysyl-L-arginyl-L-cysteinyl-,cyclic (3®17),(10®21),(16®32)-tris(disulfide)
- 17245-25-92H-1-Benzopyran-2-one,5,7-dimethoxy-8-(3-methyl-2-buten-1-yl)-
- 17245-30-64H-1-Benzopyran-4-one,3,5,6,7-tetramethoxy-2-(3,4,5-trimethoxyphenyl)-
- 17247-58-4Cyclobutane,(bromomethyl)-
- 172476-17-4Amopyroquine N-Oxide
- 172477-91-7Carbamicacid, methyl(2-pyrrolidinylmethyl)-, 1,1-dimethylethyl ester, (S)- (9CI)
- 172478-00-1Carbamic acid,N-methyl-N-3-pyrrolidinyl-, 1,1-dimethylethyl ester
- 172478-01-2Carbamic acid,N-methyl-N-3-piperidinyl-, 1,1-dimethylethyl ester
- 172478-10-3D-Proline, 1-(phenylmethyl)-, ethylester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid